Saccular limited dorsal myeloschisis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:645354Q76.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Saccular limited dorsal myeloschisis is a rare congenital spinal dysraphism classified as a form of limited dorsal myeloschisis (LDM). In this condition, there is a focal defect in the dorsal midline of the spinal cord where a stalk of abnormal tissue (the myeloschisis stalk) connects the spinal cord to the skin surface, and the overlying skin forms a visible sac-like (saccular) outpouching on the back. Unlike open neural tube defects such as myelomeningocele, the neural tissue in limited dorsal myeloschisis remains covered by skin, making it a form of closed spinal dysraphism. The saccular variant is distinguished from the flat variant of LDM by the presence of this prominent skin-covered sac, which can sometimes be mistaken for a meningocele or lipomyelomeningocele. The condition primarily affects the central nervous system, specifically the spinal cord and its surrounding structures. Key clinical features may include a visible midline dorsal skin lesion (the sac), and patients may present with or develop neurological symptoms including lower limb weakness, sensory changes, bowel and bladder dysfunction, and orthopedic deformities of the feet or spine, particularly as they grow. Tethering of the spinal cord by the myeloschisis stalk is a major concern, as progressive tethered cord syndrome can lead to worsening neurological deficits over time. Some patients may be neurologically intact at birth, with symptoms developing later in childhood. Treatment is primarily surgical and involves untethering of the spinal cord by excising the fibroneural stalk that connects the cord to the skin, along with removal of the saccular component. Early surgical intervention is generally recommended to prevent progressive neurological deterioration from cord tethering. Outcomes depend on the degree of neurological involvement at the time of diagnosis and the success of surgical untethering. Long-term follow-up is important to monitor for re-tethering and progressive neurological changes.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Saccular limited dorsal myeloschisis.

View clinical trials →

No actively recruiting trials found for Saccular limited dorsal myeloschisis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Saccular limited dorsal myeloschisis community →

No specialists are currently listed for Saccular limited dorsal myeloschisis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Saccular limited dorsal myeloschisis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Saccular limited dorsal myeloschisisForum →

No community posts yet. Be the first to share your experience with Saccular limited dorsal myeloschisis.

Start the conversation →

Latest news about Saccular limited dorsal myeloschisis

No recent news articles for Saccular limited dorsal myeloschisis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Saccular limited dorsal myeloschisis

What is Saccular limited dorsal myeloschisis?

Saccular limited dorsal myeloschisis is a rare congenital spinal dysraphism classified as a form of limited dorsal myeloschisis (LDM). In this condition, there is a focal defect in the dorsal midline of the spinal cord where a stalk of abnormal tissue (the myeloschisis stalk) connects the spinal cord to the skin surface, and the overlying skin forms a visible sac-like (saccular) outpouching on the back. Unlike open neural tube defects such as myelomeningocele, the neural tissue in limited dorsal myeloschisis remains covered by skin, making it a form of closed spinal dysraphism. The saccular va

How is Saccular limited dorsal myeloschisis inherited?

Saccular limited dorsal myeloschisis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Saccular limited dorsal myeloschisis typically begin?

Typical onset of Saccular limited dorsal myeloschisis is neonatal. Age of onset can vary across affected individuals.